ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14-mutant Non-small Cell Lung Cancer.

Ken Suzawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.